ArticleJTO clinical and research reports2023

A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma.

Andreas Rimner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.